Product Details
| Product Name: RMC-9805 | CAS No.: 2922732-54-3 |
| Min. Order: 1kg | Purity: 99 |
| Supply Ability: 15KG | Release date: 2026/07/09 |
Oral covalent KRAS G12D (ON) inhibitor, when combined with CypA and active KRAS G12D, forms a ternary complex, blocking the MAPK signal, and is used in clinical studies for solid tumors with G12D mutations such as pancreatic cancer and lung cancer.
Company Profile Introduction
We help our clients achieve cost-effective improvements in their R&D productivity. Our technical and scientific teams provide reliable products and solutions to the global chemical industry, including chemical products, and custom synthesis.
With state-of-the-art manufacturing facilities and professional R&D teams, we aim to become a leading company in this industry, and we are well on that journey.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2026-06-30 | ||
| $1.00 |
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2026-06-27 | |
|
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-05-22 | ||
| $129.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-06-16 | |
|
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2026-06-30 |
- Since: 2023-01-04
- Address: Keyuan 1st Road,?Xixian New District, Xi'an City, Shaanxi Pro
INQUIRY

China